Theme: Discovering, Innovating and Engineering Future Science
Integrative Biology 2015
Integrative Biology focusing on three principles: Insight, Innovation and Integration, is providing a global platform for research that affords new insights into biological and biophysical questions, from the nano to the macroscale.
This branch of biology is typically multi- or inter-disciplinary, calling upon expertise and technologies from the physical sciences, engineering, computation, imaging and mathematics to address critical questions in biological systems.
Our Conference will provide a perfect platform addressing:
- Laudable talks by the top-notch of the global scientific community
- Sterling workshop sessions
- Remarkable Awards and Global Recognition to meritorious Researchers
- Global Networking with 50+ Countries
- Novel Techniques to Benefit Your Research
- Global Business and Networking Opportunities
- Exquisite Platform for showcasing your products and International Sponsorship
Valencia enjoyed strong economic growth over the last decade, much spurred by tourism and construction industry, handling 20% of Spain’s exports. The national biotechnology sector in Spain has continued to expand, with sector growth rates outperforming those of the previous years. In 2011, the Spanish biotech sector comprised 3,025 companies that carry out biotechnology activities and 660 companies focused on biotechnology employing a total of 202,250 professionals, which generates revenue of € 74,069 million. Biotech companies invoiced € 8,343 million, according the National Statistics Institute 2011 Survey on Technological Innovation in Companies. Valencia, being the growing hub of Science, has been perfectly chosen for the conference.
For more details, kindly follow: Integrative Biology Market Analysis
Integrative Biology 2015 invites all interested participants to join us for this esteemed event at the exquisite destination Valencia. For more: conference series.com
Track 1: Genomics and Bioinformatics:
Genomics and bioinformatics research often requires the development of new techniques utilizing Genomics and bioinformatics tools for target assessment, including both experimental protocols and data analysis algorithms, to enable a deeper understanding of complex biological systems. In this respect, the field is entering a new and exciting era; rapidly improving “next-generation” DNA sequencing technologies, Cloud computing, hadoop in genomics, now allow for the routine sequencing of entire genomes and Transcriptomes, or of virtually any targeted set of DNA or RNA molecules.
Bioinformatics is both an umbrella term for the body of biological studies that use computer programming as part of their methodology, as well as a reference to specific analysis by Bioinformatic tools for protein analysis that are repeatedly used, particularly in the fields of Structural genomics and bioinformatics in systems biology. Common uses of bioinformatics include the identification of candidate genes and nucleotides (SNPs). Often, such identification is made with the aim of better understanding the Translational bioinformatics for genomic medicine, Genomics in marine monitoring, and Applications of genomics and bioinformatics.
Genomic labs have the fastest growing market with nearly 250 universities concentrating on its research majorly to be named Whitetail Genetic Research Institute, Stanford University, National Human Genome Research Institute. Major companies concentrating on the research are Affymetrix, Applied Biosystems, Foster City, Genentech etc.
Track 2: Integrative Computational Biology:
Computational Biology, sometimes referred to as bioinformatics, is the science of using biological data to develop algorithms and relations among various biological systems. It involves the development of Tools for integrative meta-analysis, 3c-based data integration and application of Networks and OMICS data, mathematical modeling and computational simulation techniques to the study of Integrative eqtl-based analyses, High performance genomics data visualization and Laboratory information management system. The field is broadly defined and includes foundations in computer science, applied mathematics, animation, statistics, biochemistry, chemistry, biophysics, molecular biology, genetics, genomics, ecology, evolution, anatomy, neuroscience, and visualization.
Computational biology is different from biological computation, which is a subfield of computer science and computer engineering using bioengineering and biology to build computers, but is similar to bioinformatics, which is an interdisciplinary science using computers to store and process biological data with applications of Gene regulatory networks in human pathogens, Drug-target disease networks with Computational approaches to drug discovery and Integrative modeling of bio molecular complexes.
Computational Biology research has grown after the increased research in Genomics with major universities like Iowa State University, University Of California, and The George Washington University Concentrating on the growing topic. The Bisti Consortium has even launched the NIH and Government Programs and Initiatives in Biomedical Informatics and Computational Biology (BICB) with a list of programs concentrating on Computational Biology Research.
Track 3: Drug Discovery and Integrative Biology:
Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Modern drug discovery involves the identification of Enzyme inhibitors in drug discovery, Strategies and challenges in drug discovery and Dynamics of structure based drug discovery, selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to increase the half-life), and oral bioavailability. Once a compound that fulfills all of these requirements has been identified, it will begin the process of drug development prior to clinical trials. One or more of these steps may, but not necessarily, involve computer-aided drug design.
Cancer and drug discovery involves Multi target paradigm in drug discovery with unique Systems approach for drug discovery from herbal medicine. Discovering drugs that may be a commercial success, or a public health success, involves a complex interaction between investors, industry, academia, patent laws, regulatory exclusivity, marketing and the need to balance secrecy with communication. Meanwhile, for disorders whose rarity means that no large commercial success or public health effect can be expected, the orphan drug funding process ensures that people who experience those disorders can have some hope of pharmacotherapeutic advances like Anti-fungal drug discovery and In vitro method evaluation in drug discovery to name the major few.
Drug Discovery research has the major growing market with applications in pharmaceuticals and medicine and thus major companies like Bristol-Myers Squibb Company, Isis Pharmaceuticals, Inc. , Merck & Co. Inc. and Johnson & Johnson focusing on the growing industry. Without a doubt it has become a primarily subject with increasing interest and thus more than 150 universities have come up with the curriculum; to be majorly mentioned as University of Bath, University of Dundee, University of Birmingham, The University of Edinburgh and Drexel University College of Medicine.
Cell biology (formerly cytology, from the Greek kytos, "contain") is a branch of biology that studies cells – their physiological properties, their structure, the organelles they contain, interactions with their environment, their life cycle, division, death and cell function. This is done both on a microscopic and molecular level diversifying the field to Stem cell biology, Tumor cell biology, and Cell biology through proteomics importantly.
Cell biology research encompasses both the great diversity of single-celled organisms like bacteria and protozoa, as well as the many specialized cells in multicellular organisms such as humans, plants, and sponges. The advancing Live cell imaging encompasses its applications to Biochips for cell biology, Single-cell ros imaging and Experimental models and clinical transplantation in cell biology and indeed many more.
The National Science Foundation has come up with great funding opportunities for Cell Biology Research and major universities has concentrated on the study for Cell Biology has always been basis of study formerly, to name majorly Harvard University, Universities of Virginia, Yale School of Medicine and The University of Illinois. The Research has attracted funding grants from NIH too for its increasing interest among researchers.
Tissue is a cellular organizational level intermediate between cells and a complete organ. Tissue engineering is the use of a combination of cells for Characterization of engineered tissues, engineering and materials methods to study the Advanced technologies in tissue assembly for New insights into regenerative tissue, and suitable biochemical and physicochemical factors to improve or replace biological functions. While it was once categorized as a sb-field of biomaterials, having grown in scope and importance it can be considered as a field in its own right.
Major universities as of University of California San Francisco, University of Pennsylvania and Leigh University has come up with the research of Tissue Biology encouraging and attracting students round the globe for the same.
Track 6: Developmental Biology:
Developmental biology is a great field for scientists who want to integrate different levels of biology. It talks majorly about Radical biology and medicine, Marine biology classifying species based on the environment rather than on taxonomy, also talking about the study of microbial and faunal activity and ecology in Soil biology and Theoretical biology encompassing the theoretical aspects of the emerging branch.
Again National Science Foundation has bought its focus on Developmental Biology Branch too for funding and encouraging research. The Welcome Trust too supports the Four Year PhD programme with its funding to encourage the growing research interest in the field.
Biological engineering (Cellular and Molecular Bio-Engineering) or bioengineering (including biological systems engineering) is the application of concepts and methods of biology (and secondarily of physics, chemistry, mathematics, and computer science (In vitro testing in bioengineering) to solve real-world problems related to the life sciences or the application thereof, using engineering's own analytical and synthetic methodologies (defined as Synthetic bioengineering) and also its traditional sensitivity to the cost and practicality of the solution(s) arrived at. In this context, while traditional engineering applies physical and mathematical sciences to analyze, design and manufacture inanimate tools, structures and processes, biological engineering uses primarily the rapidly developing body of knowledge known as molecular biology to study and advance applications of living organisms and to create biotechnology like Cancer Bioengineering used for Organ bioengineering and regeneration.
Bio-engineering study remains the main interest of research with more than 340 schools focusing on it majorly being Johns Hopkins University in Baltimore, Georgia Institute of Technology, University of California - San Diego, University of Washington, Stanford University and the list goes on.
Systems Toxicology is the integration of classical toxicology with quantitative analysis of large networks of molecular and functional changes occurring across multiple levels of biological organization. Society demands increasingly close scrutiny of the potential health risks associated with exposure to chemicals present in our everyday life, leading to an increasing need for more predictive and accurate risk-assessment approaches. Developing such approaches requires a detailed mechanistic understanding of the ways in which xenobiotic substances perturb biological systems and lead to adverse outcomes. Thus, Systems Toxicology approaches offer modern strategies for gaining such Investigatory findings by Infusion toxicology techniques and Computational toxicology.
Furthermore, Systems Toxicology is a means for the identification and application of biomarkers for improved safety assessments by Pharmacology investigations in toxicology testing. In Systems Toxicology, quantitative systems-wide molecular changes in the context of an exposure are measured, and a causal chain of molecular events linking exposures with adverse outcomes (i.e., functional and apical end points) is deciphered. Mathematical models are then built to describe these processes in a quantitative manner. The integrated data analysis leads to the identification of how biological networks are perturbed by the exposure and enables the Developmental and reproductive toxicology processes. This perspective integrates current knowledge regarding bioanalytical approaches, computational analysis, and the potential for improved risk assessment.
Many Companies have focused their products on Systems Toxicology Research like Mitsui Zosen Systems Research Inc., Alere US and Eurotox to name a few. The IBIS World provides a detailed Market Report of the growing Toxicology Market and thus the effectiveness of the research.
Track 9: Ecology and Evolution:
Ecology and Evolutionary Biology lies at the intersection of ecology and evolutionary biology. It approaches the study of ecology in a way that explicitly considers the evolutionary histories of species and the interactions between them. Conversely, it can be seen as an approach to the study of evolution that incorporates an understanding of Ethno biology and Conservation of Natural heritage. The main subfields of evolutionary ecology are life history evolution, Social ecology and sustainability, the evolution of interspecific relations (cooperation, predator-prey interactions, parasitism, Investigations of genetic load and mutualism) and Population Ecology and Ecosystem.
Ecology and Evolution has been a prime concern for researchers and environmentalists for the growing environmental issues. Some of the major universities concentrating being Stanford University, The University of Arizona focusing specially on Population Ecology, University of Illinois, University of Michigan and The University of Kansan with indeed the number going upto 600.
Systems biology is the study of Theoretical aspects of systems biology of biological components, which may be molecules, cells, organisms or entire species. Living systems are dynamic and complex and their behavior may be hard to predict from the properties of individual parts.
It involves the computational (involving Insilico modeling in systems biology, Biomarker identification in systems biology) and mathematical modeling of complex biological systems. An emerging engineering approach applied to biomedical and biological scientific research, systems biology is a biology-based inter-disciplinary field of study that focuses on complex interactions within biological systems, using a holistic approach (holism instead of the more traditional reductionism) to biological and biomedical research involving the use of In vitro regulatory models in systems biology using OMICS tools. Particularly from year 2000 onwards, the concept has been used widely in the biosciences in a variety of contexts.
Many Funding Opportunities in this research has been bought up by Support ISB, National Science Foundation, NIH and many Collaborative Funding Opportunities.
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
|Conference Date||August 04-06, 2015|
|Sponsors & Exhibitors||
|Speaker Opportunity Closed||Day 1||Day 2||Day 3|
|Poster Opportunity Closed||Click Here to View|
All accepted abstracts will be published in respective Our International Journals.
Abstracts will be provided with Digital Object Identifier by